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Causation By Presumption? Why the Supreme Court Should
Reject Phantom Losses and Reverse Broudo
by John C. Coffee, Jr.*

Abstract
The Supreme Court is about to hear Dura Pharmaceuticals Inc. v. Broudo, a case in which the
Ninth Circuit significantly liberalized the “loss causation” standards applicable to federal securities
litigation. In response to a companion article by Professor Merritt Fox, which favors such a liberalization
and even the abandonment of loss causation as a necessary element, Professor Coffee argues that any
change in causation standards that permits a plaintiff to escape showing a decline in the security’s stock
market price attributable to the material misstatement or omission gives rise to perverse incentives, which
would likely result in the award of phantom losses that may have been caused instead by other factors, such
as a market bubble. More generally, he argues that the securities class action against the corporate
defendant in cases of secondary market stock drops appears to serve little legitimate function, advancing
neither compensatory nor deterrent ends. Instead, such actions against the corporation (as opposed to
actions against gatekeepers, controlling persons or the corporation in the primary market setting)
principally effect inefficient wealth transfers among largely diversified shareholders. Given the legal and
other transaction costs involved, shareholders appear likely to be net losers from such actions. As a result,
he concludes that further minimization of the causation requirement should await policy clarification of the
role of the “fraud on the market” action against a non-trading issuer defendant.

Over a quarter of a century ago, Judge Henry Friendly coined the term “fraud by
hindsight” in upholding the dismissal of a proposed securities class action.1 As he
explained, it was too simple to look backward with full knowledge of actual events and
allege what should have been earlier disclosed by a public corporation in its SEC filings.
Because hindsight has 20/20 vision, plaintiffs could not fairly “seize upon disclosures” in
later reports, he ruled, to show what defendants should have disclosed earlier.2
Today, a parallel concept – “causation by presumption” – is before the Supreme
Court, and it too deserves to be rejected. At issue is whether a loss that never actually
occurred in the real world – but arguably would have if other events had not intervened or
if full corrective disclosure had been made – can support a Rule 10b-5 cause of action
against a public corporation. The key problem with such a hypothetical determination of
loss involves the limited institutional competence of judges and juries to infer losses.
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Generally, markets determine the loss, and the judicial system (judges and juries)
allocates it among the parties to a litigation. This makes sense; markets know best what
information to value, and the legal factfinder can best make the normative judgments
about the defendant’s requisite culpability and relative fault.3
Yet, under Broudo v. Dura Pharmaceuticals, Inc.,4 the case now before the
Supreme Court, the judicial system (and typically the jury) would potentially determine
both. Losses uncorroborated by any form of market reaction to the discovery that material
information had been misstated or omitted could be awarded. For example, in the absence
of such a market reaction, the jury could determine that the stock price was inflated –
even though the market price of the stock either never declined or instead declined for
entirely unrelated reasons. Broudo’s approach has been formalized by my able colleague
Professor Merritt Fox in his companion article. Under his proposed methodology, once
“the plaintiff successfully pleads that the misstatement is material, there would be for
pleading purposes a presumption that the misstatement inflated the purchase price.”5 This
is what I term “causation by presumption,” because its net effect is to eliminate any real
obligation to show a causal connection between a material misrepresentation or omission
and any actual stock market decline. This premise that because material adverse
information was not disclosed, the price must therefore have been inflated is, however,
highly questionable. That a jury finds a fact to be material does not mean that the market
would have given it weight. To say this is not to reject efficient market theory, but only to
recognize that the factfinder’s conclusion is not the judgment of that market.
More generally, permitting such hypothetical loss determinations without
corroboration from any actual market movement expands the role of courts and juries
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beyond their historical domain (which was to allocate losses that demonstrably existed)
and shrinks the role of the market. Ultimately, markets, rather than courts, are better at
determining the extent of the loss, if any, that has occurred, even if the market reaction
may sometimes mask a possible loss because of offsetting positive and negative
developments. Part I of this comment will examine the practical implications of Broudo’s
approach to causation.6
Part II then turns to Broudo’s policy implications for securities class actions and
shareholder welfare. Rule 10b-5 class actions tend disproportionately to be secondary
market class actions in which the defendant corporation has neither bought nor sold its
own shares during the relevant period. Within this context, the need for a market
corroboration of a loss seems strongest because such a securities class action essentially
pits one class of shareholders (those who traded within the class period) against all other
shareholders. Inherently, in the secondary market context, such actions generate wealth
transfers from the latter class of generally non-culpable shareholders to the former class.
Why we should wish to maximize the number and amount of these intrashareholder wealth transfers is a question that seems to have escaped serious policy
debate. But such a debate is needed because these transfers seem likely to produce net
losses in the real world, once the considerable transactions costs extracted by the legal
profession are subtracted. Broudo does not create this problem, but it exacerbates it. Thus,
although Professor Fox incisively explains the incongruence between traditional reliance
theories and the context of secondary trading in an efficient market, his analysis ducks
the real policy issue: namely, the legitimacy of maximizing wealth transfers among
generally diversified shareholders. Until this issue is placed at the forefront of any policy
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analysis, discussions of presumptions and burdens of proof merely rearrange the deck
chairs on the Titanic.
In fairness to Professor Fox, his doctrinal history is succinct and accurate, and he
clearly demonstrates that transaction causation is logically irrelevant to this open market
context (and in fact courts have quietly dispensed with it). But his attempt to dispense
similarly with loss causation takes him, I believe, a bridge too far. Eliminating loss
causation (or replacing it with a presumption) forces the corporate defendant to act as an
insurer who must compensate shareholders who traded within the class period for losses
that may have only a tenuous relationship with any misrepresentation it made. The cost of
such insurance is not only expensive, but it provides no real benefit for diversified
shareholders who fall into both classes and thus wind up effectively transferring wealth
from one pocket to another (minus considerable legal costs). For all these reasons, little
policy justification exists to further liberalize the standards applicable to secondary
market Rule 10b-5 litigation against a non-trading issuer.
Part III will turn to doctrinal and statutory issues. The approach of both Broudo
and Professor Fox conflict with the methodology that the Supreme Court has laid out for
construing Rule 10b-5’s contours: namely, as an implied cause of action, Rule 10b-5
must mirror the most closely comparable express cause of action. In fact, the most closely
comparable provisions define loss causation so as to focus exclusively on the
“depreciation in value” of the security, thereby implying that initial price inflation at the
time of purchase without subsequent “depreciation in value” is insufficient.7 In addition,
the Private Securities Litigation Reform Act of 1995 (the “PSLRA”) makes proof of loss
causation mandatory in a Rule 10b-5 action, and it clearly assigned the burden of proof
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on that issue to the plaintiff. This allocation of the burden is frustrated, however, if courts
recognize a presumption of causation based only on a proper pleading of materiality.
Current law also draws an entirely sensible distinction between the primary and
secondary market contexts, placing the burden on the plaintiff of proving loss causation
in the secondary market context, but shifting it to the defendant to disprove loss causation
in the primary market context.8 This distinction would be frustrated if merely pleading
that a misstatement “inflated” the issuer’s stock price could suffice to satisfy the loss
causation standard in the secondary market context (because such proof will clearly not
work in the primary market context).9
I. What’s At Stake in Broudo
In Broudo, the defendant Dura Pharmaceuticals announced lower than forecast
earnings in February, 1998 and suffered a very sharp drop in its stock price (47% in one
day).10 This was the only stock price decline that plaintiffs alleged (or that otherwise
appears in the record). Plaintiffs did allege, however, that materially false misstatements
were made over an approximately nine month period from April, 1997 to January 1998,
which preceded the February 1998 earnings surprise. These misstatements related to an
asthma medication delivery device that Dura was developing. Ultimately, in November,
1998, Dura announced that the Federal Drug Administration had refused to approve this
product, but plaintiffs did not allege that the market declined in response to this
announcement.11
Although the district court dismissed the complaint in Broudo for failure to plead
“loss causation,”12 the Ninth Circuit reversed, finding that the plaintiff need not plead any
causal connection between the misstatement and a subsequent decline in price, but only
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need plead “that the price at the time of purchase was overstated and sufficient indication
of the cause.”13 The Supreme Court granted certiorari on this issue.14
Professor Fox believes that the Ninth Circuit got it right. Because the market was
efficient, Dura’s allegedly false statement “can be presumed to have inflated the price
paid for its shares.”15 “Thus,” he concludes, “the pleadings are satisfactory as to
causation.”16 In short, the plaintiff need only plead price inflation, and not that the stock
price subsequently fell. From an economic perspective, Professor Fox’s theory is
coherent: if you make a material misstatement, it must inflate the market price and so the
shareholders purchasing at that inflated price are injured. But from a legal and
institutional perspective, this presumption is more suspect, and in any event the law of
fraud has never condensed to this simple and skeletal a formula.17
Initially, it is important to focus on the incentive effects created by this theory that
the plaintiff need only allege price inflation. Under such an interpretation of Broudo,
materiality subsumes causation. Once materiality is shown, some price inflation is to be
presumed. As a result, the practical impact of this rule would be to give plaintiff’s
attorneys a strong and seemingly perverse incentive to search the stock market for
significant stock price declines and then seek to allege that some material information
had been withheld or misstated – even if, as in Broudo, other developments (i.e., the
earnings shortfall in that case) seemed to explain better the stock price decline.
To illustrate, assume that Foreign Corporation, whose stock is actively traded in
the U.S. market, is suddenly nationalized or simply shut down by its home country, and
its price falls from $50 per share to zero. The proximate cause of this loss may seem
obvious, but if plaintiffs can plausibly allege that Foreign Corporation had inflated its
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financial statements so that its true intrinsic value was only $30 per share at the time that
class members purchased its stock, then, under Broudo, they can sue for this $20 worth of
inflation – even though there is no market corroboration that any misstatement would
have had such an impact. To be sure, some allocation of the loss would be necessary
between the non-fraudulent causes of the stock price decline and the alleged material
misstatements or omissions. But this would not need to be done until one reached the
damages stage of the action. In the real world of securities class action litigation, this
stage is seldom reached.
The practical impact of eliminating any requirement that the plaintiff plead a
causal connection to a subsequent stock decline is that many more cases would survive
dismissal at the pleading stage, because the plaintiff’s attorney would only have to plead
materiality and scienter. At trial, the plaintiff’s attorney could plausibly assert that some
portion of the stock drop was attributable to the market’s discovery of some or all of the
undisclosed or misstated material facts (even if most of the stock drop seemed more
attributable to a fully disclosed cause). Or, alternatively, the plaintiff could assert that the
stock price was still inflated.18 While Professor Fox makes clear that he would not allow
damages without some actual decline in the stock’s value, Broudo is far less clear and
might allow a recovery even in the absence of a stock market decline.
In practice, the most likely scenario under Broudo would be something like this:
A high-tech company fails to disclose that a key patent may not be valid and enforceable
because it infringes on that of a rival company. Plaintiffs assert that the stock, which has
long traded at $100 per share, is really worth only $70 because of this problem. But
before any disclosure is made, all of the company’s senior management dies in a crash of
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their corporate jet, and, without them, this start-up company cannot continue. The stock
price falls to $10.19 Alternatively, there may be no plane crash and instead newspaper
stories reveal that the company faces some patent litigation; in response, the market price
responds partially, falling only to $90 per share. Still, plaintiffs assert that because the
full truth has not been revealed, the stock is still inflated, and its actual value is only $70.
Either way, how should we answer Professor Fox’s claim that the shareholders
who bought at $100 were truly injured at the time of their purchase by the company’s
failure to disclose a material problem with its patents and thus they should be able to
recover the difference between $100 and the stock’s alleged “intrinsic value” of $70 –
without showing any market correction attributable to the misstatement or omission?
Several different answers can be given that all reiterate the basic theme that the loss here
is simply too speculative and indefinite in the absence of any evidence that the market
considered the stock to have been overvalued because of the alleged patent problem. First,
even if judges and juries simply are competent to determine the materiality of the
misstatement, they cannot reliably measure its financial impact in the absence of some
market evaluation of the corrected disclosure. Was the material nondisclosure worth $10
or $70? Juries generally do not have a clue. Second, even if material adverse information
was not disclosed (as in the foregoing patent hypothetical), material positive information
may have also been withheld for proprietary reasons, so that the $100 purchase price did
in fact reflect intrinsic value (or even fell below intrinsic value). This is not implausible,
because corporations have an incentive to withhold proprietary information from their
competitors.20 Third, the nondisclosure of the patent problem went to a risk that might or
might not materialize. In fact, if it had been disclosed, assume that the market price
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would have sunk temporarily to $70, but ultimately it would have rebounded to $100, or
more, when the company won the patent litigation. Why should non-selling shareholders
be compensated for only a temporary decline in their corporation’s stock price that never
affected them?
Finally and most importantly, the stock may have been inflated, but the real cause
was a market bubble.21 The plaintiff shareholders may have purchased in the secondary
market in the aftermath of an IPO, when the stock price soared, pushed upward by an
overheated market.22 Thus, the price inflation may not be attributable to any misstatement,
even if a material misstatement were made. Hence, to hold the issuer liable on these facts
is to make it an insurer for the market’s “irrational exuberance.” But again, this results in
a system of extraordinarily expensive self-insurance for diversified investors, which they
clearly would not purchase if given the choice. Endless variations on all these themes can
be posed, but the major point here is that the jury’s inference of what the market price
would have been had the misstatement or omission not been made involves a speculative
judgment in which we can have little confidence.
Professor Fox characterizes my objections as “evidentiary” in nature and adds that
I appear “to have little trust in the ability of the judge at summary judgment and the jury
at trial to deal reliably” with these issues.23 He then suggests that judges and juries can
deal “sensibly” with these issues.24 This is, of course, an empirical issue. The latest data
shows that on a percentage basis few securities class actions are dismissed before trial
and that even this low rate has dropped significantly since the passage of the SarbanesOxley Act.25 While dismissal rates vary significantly by Circuit, in the Second and Ninth
Circuits, which have the highest volumes of securities class action litigation, only 8% and
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6%, respectively, of all securities class actions were dismissed within two years of the
action’s filing.26 In short, even with today’s strict rules (in most Circuits) on loss
causation, only a low percentage of securities class actions are dismissed, and Professor
Fox would liberalize the pleading standard so that even fewer would be dismissed. This is
not a small point. Procedurally, courts have only limited opportunities to dismiss an
action before trial, and Professor Fox’s proposal would eliminate one of these. Nor is
summary judgment an adequate substitute, because if there are triable factual issues, the
court has no discretion and must let the action proceed to trial.
The differences between Professor Fox and myself may well boil down, on the
operational level, to my insistence that procedure counts. From his ex ante perspective, it
can be argued that dropping loss causation as a necessary element in the liability equation
does not truly change much because the plaintiff still must prove damages. Arguably, the
issues that are today addressed in most Circuits under the heading of causation would
instead simply be postponed to the later stage at which damages are determined (where
the plaintiff would still bear the burden of proof). This might be correct in theory if cases
where actually litigated at this damage determination stage, but they are not. Cases that
survive pre-trial dismissal tend to be settled. Hence, any proposal to substitute a
presumption of causation for the traditional loss causation rule (as Professor Fox
proposes) substantially tilts the playing field to the disadvantage of defendants. Delaying
the issue of causation until the damages phase realistically means (i) that issue of
causation would be at least partially transferred from the court’s control to the jury’s
discretion, and (ii) the defendants would lose their current opportunity for a pre-trial
screening of the case by the court. Thus, both in terms of timing and the allocation of
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responsibility between the judge and the jury, Broudo’s rule (and, even more so,
Professor Fox’s codification of it) are adverse to defendants and will raise the settlement
value of securities class actions.
The full scope of the problems that Broudo raises comes into clearest focus only
when we consider the prospect that multiple plaintiffs, each relying on different public
statements made at different times, could all assert that the corporation’s stock price was
overvalued because of material misrepresentations made at or prior to the time they
purchased – but that this price inflation was never detected (or at least fully corrected) by
the market. To illustrate, assume that a large block of shares in Corporation X was
purchased at three different times during 2004: (i) by a state public pension fund on
April 1, 2004 at a price of $60 per share, which price was allegedly inflated because
Corporation X had failed to disclose that it used an improper accounting principle in
determining its 2003 earnings (which results had been publicly released at that point); (ii)
by a mutual fund on June 1, 2004, also at $60 per share, but a time when Corporation X
allegedly knew, but had not disclosed, that it was subject to material environmental
liabilities that were likely to be asserted eventually; and (iii) by a hedge fund on October
15, 2004, also at $60 per share, at a time when Corporation X allegedly knew, but had not
disclosed, that its principal customer had terminated their long-term exclusive dealing
agreement. Throughout this period and thereafter, Corporation X’s stock price remains
stable at $60 – until April 1, 2005 when it suddenly falls to $40 per share. Each of these
investors sues in a different court (two in federal court, and the third in state court), each
alleging that the stock price had been inflated at the time of their purchase. Under Broudo,
all they need allege is materiality and scienter. Each could win its own proceeding, each
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potentially recovering the full $20 difference per share (or more, if they convinced the
jury that the market had not yet fully corrected the inflation). Even if the defendant
introduced persuasive evidence that some extrinsic event (i.e., a change in interest rates
or a world crisis) had caused the market decline from $60 to $40 per share, plaintiffs
could still reply that the latent price inflation in their case still remained.27
Beyond the practical problems in such litigation, the greater problem in applying
“efficient market” reasoning to the context of securities litigation may be that lawyers
and economists often mean different things when they use the same words. An economist
knows that an efficient market will respond to all new material information, incorporating
it into price immediately. But a lawyer knows that the concept of “materiality,” as it is
applied in courts, is broad and liberal. A “material” fact is one as to which:
“there is a substantial likelihood that a reasonable shareholder would
consider it important in deciding how to vote.”28
This is an expansive test that asks the jury to determine if the information is “important”
to a rational decision. Such a definition is broader than the economic definition of
materiality, which typically focuses on future discounted cash flows. Facts so found to be
material under this legal standard may or may not move the market. Thus, a jury’s
determination that material facts were not disclosed does not necessarily imply that there
has been price inflation; nor should such inflation be presumed. Because the two
professions have different understandings of the same term, it is dangerous to presume
that a legal conclusion necessarily has real world implication for markets.
II. A Policy Perspective on the Secondary Market Securities Class Action
The context of secondary market trading is very different from that of the primary
market in which the corporation issues shares to investors who purchase from it. Because
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of the long-established separation of ownership and control in the United States, the vast
majority of the stock in “public” companies will be owned by dispersed shareholders
holding relatively small percentage stakes, with this ownership being divided
approximately equally between institutional investors and retail investors. When a
securities class action is brought against a public corporation that has not, itself, sold or
purchased its securities (i.e., the typical secondary market context), the action is brought
on behalf of shareholders (and former shareholders) who purchased the stock during the
“class period” (i.e., the time period during which the market was allegedly affected by
material misinformation). Any judgment or settlement in this action will be borne by the
corporation (and thus indirectly by its current shareholders).29 As a result, securities
litigation in this context inherently results in a wealth transfer between two classes of
public shareholders, neither of whom is necessarily culpable. Worse still, even if we
assume that fraud was present, the beneficiaries of the fraud are the persons who sold at
inflated prices – the selling shareholders – and they escape without incurring any cost
when liability is later imposed on their former corporation.
Equally perverse are the implications that flow from the fact that most investors
are diversified. Hence, they will belong to both the plaintiff class that sues and the
residual shareholder class that bears the cost of the litigation. Either they will have
purchased stock at times that are both inside and outside the class period, or, viewed in
the aggregate, they will own stock in many corporations that are the subject of securities
class actions, sometimes being a shareholder within the class period and sometimes not.
As a result, at least in the aggregate, diversified investors are making wealth transfers to
themselves, shifting money, as it were, from one pocket to the other – minus, of course,
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the considerable transactions costs that both sides pay to the legal profession. Indeed, if
the legal and other costs borne by the corporation are added to the fees and expenses
received by the plaintiff’s attorney, this sum on average may well exceed the net recovery
to the class.30 At a minimum, it is clear that recovery rates in securities class actions are
extremely modest: 2.8% of investor losses in 2003, up from 2.7% in 2002.31 In short, as a
mechanism for delivering compensation, securities class actions are far from successful
and may inflict increased compensatory losses on shareholders.
This is not to deny that there could be deterrent benefits from such class actions,32
but again these benefits should not be idealized or assumed. Insurance typically protects
the individual defendants (and often the corporation as well), and this cost again falls on
shareholders. Also, if only 2.7% to 2.8% of investor losses are recovered on average, this
cost may be easily absorbed by those who have an incentive to inflate the company’s
financial statements. Most importantly, for deterrence to work, the costs must fall either
on the culpable or at least on those who are the best cost avoiders – that is, those who can
take effective precautions to minimize the risks. As a practical matter, this means that
actions directed against corporate managers, controlling shareholders, auditors,
underwriters or other gatekeepers should have some desirable deterrent effect, but when
the liability simply falls on the corporation, as the residual risk bearer, the deterrent effect
is dissipated.
Finally, there is the problem of error and its costs. When liability is imposed for a
loss that was not causally related to a misstatement or omission made by the defendant,
the law generates only an unfocused deterrence, and a windfall is awarded to one class of
shareholders (typically, the selling shareholders) at the expense of other shareholders.
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Such mistakes are not costless to shareholders, because the defendants who pay will
demand a risk premium in the future before they again serve as an auditor, underwriter or
other gatekeeper. Also, such deterrence may induce overly conservative financial
reporting and/or earnings management that is intended to reduce stock price volatility and
thereby minimize the risk of future liability.
For these reasons, I find Professor Fox’s analysis too facile when he argues that
fraud-on-the market actions “deter corporate misstatements” and thereby increase “share
price accuracy.”33 To be sure, they could do so, but the impact of his proposal to drop the
loss causation requirement may be more to unfocus deterrence. To the extent that
causation is presumed based only on a showing of materiality, the likelihood grows that
cases will settle for substantial recoveries where the actual cause of the stock market
decline was unrelated. The costs of these settlements would fall like a tax on all
shareholders, and such unfocused deterrence may do more harm than good. No policy
rationale seems discernible that justifies liberalizing the standards applicable to causation
in order to encourage this type of litigation (as opposed to actions against the truly
responsible actors).
III. The Battle in the Doctrinal Trenches: How the Court Is Likely to Rule
Although Professor Fox and I have debated loss causation on an abstract level, the
Supreme Court will likely resolve this issue on a far more pedestrian and doctrinal level,
following an approach that it has laid out in earlier decisions. As the Court noted in
Lampf, Pleva, Lipkind, Prupis & Petigrow v. Gilbertson,34 Rule 10b-5 is a judicially
fashioned, implied cause of action, one that Congress never really enacted. In such a
context, the Court concluded, the scope and contours of this implied cause of action must
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parallel the nearest similar express cause of action.35 In Lampf, Pleva, the Court found
Sections 9 and 18 of the Securities Exchange Act of 1934 to constitute the closest
“comparable express remedial provisions,” and thus it looked to their statutes of
limitations to determine the applicable statute of limitations for Rule 10b-5.
A brief examination of these two sections shows that both also contemplate that a
plaintiff must prove loss causation. For example, Section 18 expressly authorizes a suit to
be brought for a misleading statement in an SEC filing, but only by a person “who, in
reliance upon such statement, shall have purchased or sold a security at a price which was
affected by such a statement, for damages caused by such reliance ….”36 This language
seems to require both traditional reliance and that the stock price be “affected” by the
misstatement.37 Finally, because Section 18 limits recoverable damages to the “damages
caused by such reliance,” it expressly requires a causal connection. But this language
may not answer all questions. If the stock price was inflated by a misleading statement
and has not fallen in response to any corrective disclosure, the plaintiffs will predictably
claim that they have suffered “damages caused by such reliance” on the theory that the
price inflation represents their “damages”. That such latent inflation constitutes
recoverable “damages” seems dubious to me, but the statutory language is at least
susceptible to divergent readings.
If Section 18 does not clearly resolve the issue of whether alleging price inflation
is sufficient, it may answer a much more important question, because the express
language of Section 18 permits the Court to reconsider Basic v. Levinson,38 which
established the current doctrinal formula that the plaintiff in an efficient market relies on
the “integrity of the price set by the market.”39 Because Section 18 expressly requires
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actual reliance on the statement, itself, it follows that, if Section 18 is the appropriate
template to which Rule 10b-5 must conform, then reliance on the “integrity of the price
set by the market” would be insufficient to establish causation for Rule 10b-5 purposes.40
Section 9 of the Securities Exchange Act of 1934 also contains similar language
that requires that the plaintiff purchase or sell the “security at a price which was affected
by such act or transaction.”41 Again, this language arguably could be read to cover price
inflation without a subsequent market correction (i.e., the facts of Broudo), but Section
9(e) does limit the damages recoverable to the “damages sustained as a result of any such
act or transaction.”42 If the market has not corrected, it seems more questionable here
than under Section 18 that the holder of stock at an inflated price has “sustained” any
damages.43
In any event, the issue of loss causation under Rule 10b-5 is more directly
addressed by the PSLRA, which added Section 21D(b)(4) to the Securities Exchange Act
of 1934. It provides:
(4) Loss Causation. – In any private action arising under this title, the
plaintiff shall have the burden of proving that the act or omission of the
defendant alleged to violate this title caused the loss for which the plaintiff
seeks to recover damages.44
This provision clearly assigns the burden of proof on loss causation to the plaintiff.
Hence, Professor Fox’s view that courts should create a presumption of causation based
on a proper pleading of materiality reverses Congress’s allocation of the burden of proof.
On the other hand, the above provision does not clearly state that proving price inflation
is insufficient or that there must be a subsequent price decline following corrective
disclosure.
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Still, Section 21D(b)(4) clearly intends to refer to an established doctrine called
“loss causation.” The contours of this established doctrine are clearly set forth in Section
548A of the Restatement (Second) of Torts, which states that:
“one who misrepresents the financial condition of a corporation in order to
sell its stock will become liable to a purchaser who relies upon the
misinformation for the loss that he sustains when the facts as to the
finances of the corporation become generally known and as a result the
value of the shares is depreciated on the market.”45
Clearly, this definition requires a market correction and is not satisfied simply by the
claim that the stock price was inflated at the time of purchase.46
Two last statutory arguments may be more dispositive. First, Section 12(b) of the
Securities Act of 1933 was added by the PSLRA at the same time as Section 21D(b)(4)
was added to the Securities Exchange Act of 1934.47 It expressly disallows from the
damages recoverable under Section 12 “any portion or all of the amount recoverable …
other than the depreciation in value of the subject security resulting from such part of the
prospectus or oral communication … not being true ….”48 In short, only the
“depreciation in value,” not the original price inflation, can be recovered. Of course,
Section 12 of the 1933 Act is addressing the primary market, not the secondary market
addressed by Rule 10b-5 and Section 21D(b)(4). Yet, it seems self-evident that stricter
standards should apply in the latter case where the defendant did not trade and is sued as
a de facto insurer. After all, in both Sections 11 and 12 of the 1933 Act, the two primary
market anti-fraud provisions, Congress placed the burden of disproving loss causation on
the defendant,49 while in Section 21D(b)(4), which applies to Rule 10b-5, it squarely
places that burden on the plaintiff. Although the burden of proof is different between the
loss causation provisions in the two statutes, there is no reason to believe that Congress
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wanted the concept of loss causation to be substantively different in the two statutes.50 If
anything, Congress wanted loss causation to be a greater barrier to a plaintiff’s recovery
under the 1934 Act than under the 1933 Act, which is why it assigned the burden of proof
to the plaintiff under the 1934 Act. It would frustrate this intent, and indeed reverse the
relative significance of the loss causation provision in the two statutes, if loss causation
were defined not to require a post-purchase “depreciation in value” under the 1934 Act.
Hence, Section 12(b) of the Securities Act of 1933 should be read in pari materia with
Sections 21D(b)(4) of the Securities Exchange Act of 1934.
A second statutory argument flows out of Section 21(D)(e) of the Securities
Exchange Act of 1934, which was also added by the PSLRA in 1995, and which places a
ceiling on damages so that they may not exceed the difference between the purchase price
paid by the plaintiff (where the plaintiff is a buyer):
“and the mean trading price of that security during the 90-day period
beginning on the date on which the information correcting the
misstatement or omission that is the basis for the action is disseminated to
the market.”51
This language was expressly drafted to limit damages under Rule 10b-5 when the stock
price rebounds after an initial decline (as it did in Broudo).52 Clearly, it assumes that
there will be a market correction before there can be liability and then seeks to exclude
short-term market corrections (probably because it considered them to be more the
product of market volatility than actual fraud). Although this provision’s intent was to
deny damages when there is an immediate price rebound, this language logically also
precludes liability when there is no decline (even if the stock price remains “inflated”).53
Conclusion
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When it is decided, Broudo could resolve a lot or only a little. It could reconsider
Basic v. Levinson, which could be significantly curtailed in the light of the PSLRA and
Lampf, Pleva.54 Or, the Court could simply accept the position of Solicitor General that
the plaintiff must plead and prove some post-purchase decline in value of the security in
order to satisfy loss causation. The Solicitor General’s position is extremely modest
because it requires only that “the inflation in the price of the security attributable to the
misrepresentation was eliminated or reduced.”55 That the inflation only need be
“reduced” requires very little, and the Solicitor General’s brief even argues that “a drop
in the stock price may not be a necessary condition for establishing loss causation in
every fraud-on-the-market case.”56 Surprisingly, it goes even further to suggest that the
“inflation attributable to a misrepresentation might be reduced or eliminated even if there
were a net increase in price.”57
If this is all that the decision holds, its impact will be very modest indeed. Instead,
the Court should rule that because Section 12(b) of the 1933 Act and Section 21D(b)(4)
of the 1934 Act are to be read in tandem, there must be a stock price decline and only
“depreciation in value” attributable to a material misstatement or omission can be
recovered under Rule 10b-5, at least in the secondary market context of a company traded
in an active securities market.58
The debate over Broudo and loss causation also shows the dangers in a shotgun
marriage of law and economics. Procedure counts, and its goals and concerns tend to be
excessively discounted by a purely ex ante approach to law and litigation. In particular,
the concept of materiality means different things to lawyers and economists. Plugging a
jury’s legal conclusion that an omitted fact was material into the framework of efficient
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market theory makes little sense. Preserving judicial discretion and pre-trial screening of
cases makes more sense, and the traditional loss causation doctrine does that, at least to a
degree. Ultimately, the issue that most needs informed debate is the issue that will
probably be ignored in the eventual Broudo decision: the legitimacy of making the
public corporation an insurer for market declines in open-market trading cases where the
corporation, itself, has not traded.
*

Professor Coffee is the Adolf A. Berle Professor of Law at Columbia Law School and Director of its

Center on Corporate Governance.
1

See Denny v. Barber, 576 F.2d 465, 470 (2d Cir. 1978).

2

Id.

3

These are the critical decisions for the factfinder in Rule 10b-5 litigation. Did the defendant act with the

requisite scienter? What “percentage of responsibility” does the defendant bear in proportion to others? See
Section 21D(f)(2) of the Securities Exchange Act of 1934 (mandating proportionate liability unless the
defendant had actual knowledge of the misstatement). 15 U.S.C. 78u-4(f)(2).
4

339 F.3d 933 (9th Cir. 2003), cert. granted, 2004 U.S. LEXIS 4605 (June 28, 2004). Broudo did not come

from out of the blue. It follows an earlier Ninth Circuit decision that also held that damages could be
measured at the time of the purchase transaction and did not require a subsequent decline for a loss to be
sustained. See Knapp v. Ernst & Whinney, 90 F.3d 1431, 1438 (9th Cir. 1996). But see cases cited infra at
note 17 (holding that time of purchase price inflation is insufficient).
5

See Merritt Fox, Demystifying Causation in Fraud-on-the-Market Actions, _ Bus. Law. _ at [20] n. 46.

6

The topic of causation is the source and subject of endless debate in academic legal circles, particularly as

it relates to tort law (as it does here). See, e.g., H.L.A. Hart & T. Honore, CAUSATION IN THE LAW (2d
ed) (Clarendon Press 1985); L. Green, The Causal Relation Issue in Negligence Law, 60 Mich. L. Rev. 543
(1962). Hopefully, the Supreme Court will resolve this issue before academics can muddy these waters
further.
7

See text and notes infra at notes 47 to 52.

- 22 -

8

See text and notes infra at notes 48 to 49.

9

As discussed infra, Sections 11(e) and 12(b) of the Securities Act of 1933 disallow losses other than the

“depreciation in value” of the security attributable to the misstatement. An “inflated” stock has by
definition not depreciated, and only the decline can be recovered under these sections. See text and note
infra at note 49.
10

See Brief for the United States As Amicus Curiae Supporting Petitioners in Dura Pharmaceuticals, Inc. v.

Broudo (September, 2004) (hereinafter, “Brief for the United States”) at p. 2.
11

According to the amicus brief for the United States, Dura’s stock price fell after the November, 1998

disclosure from $12 3/8 to $9 3/4. However, within twelve trading days, Dura’s stock price rose above the
pre-announcement price to approximately $12 1/2. See Brief for the United States at p. 3. Plaintiffs did not
allege any damages because of this decline. Professor Fox suggests that this may have been an oversight on
their part. More likely, however, plaintiffs omitted any such reference because of the impact of the Private
Securities Litigation Reform Act of 1995, which disallows short-term stock losses when the stock price
rebounds. See Section 21D(e)(1) of the Securities Exchange Act of 1934, 15 U.S.C. § 78u-4(e), (requiring
that damages not exceed the difference between purchase price and mean trading price over the 90-day
trading period “beginning on the date on which the information correcting the misstatement or omission
that is the basis for the action is disseminated to the market”). This language also seems to require a
corrective disclosure and a downward market movement as a precondition to damages, thus implying that
price inflation alone is insufficient. See text infra at note 51.
12

In re Dura Pharms. Inc. Sec. Litig., 2000 U.S. Dist. LEXIS 15258 (S.D. Cal., July 11, 2000).

13

Broudo, 339 F.3d at 938.

14

The Brief for the United States in Broudo defines the issue before the Court as: “Whether a securities

fraud plaintiff invoking the fraud-on-the-market theory must demonstrate loss causation by pleading and
proving a causal connection between the alleged fraud and the investment’s subsequent decline in price.” Id.
at p. I. The Solicitor General answers this question in the affirmative but would under some circumstances
permit a loss uncorroborated by any market movement to suffice. I believe this is a fairly weak compromise.
See text and notes infra at notes 55 to 57.
15

See Fox, supra note 5, at [38].

- 23 -

16

Id.

17

Even in Basic v. Levinson, 485 U.S. 224 (1988), the Court did insist that “reliance is an element of a

Rule 10b-5 cause of action” and that the plaintiff must demonstrate “the requisite causal connection
between a defendant’s misrepresentation and a plaintiff’s injury.” Id. at 243. Cases in a number of Circuits,
both before and after Broudo, have reached contrary results, finding that a pleading of price inflation alone
is insufficient to plead loss causation. See, e.g., Emergent Capital Inv. Mgmt., LLC v. Stonepath Group Inc.,
343 F. 3d 189, 198 (2d Cir. 2003); Semerenko v. Cendant Corp., 223 F.3d 165, 185 (3d Cir 2000); Robbins
v. Koger Props. Inc., 116 F.3d 1441, 1448 (11th Cir. 1997). The Restatement (Second) of Torts also takes a
contrary approach in its definition of the requisite element of loss causation. See infra at notes 45 to 46.
18

Admittedly, the plaintiff would be more rational in such a setting simply to sell his inflated shares before

they fell in value, but an indexed institutional investor might claim that it needed to hold the stock to
maintain a diversified portfolio.
19

This example roughly corresponds to the example given in Restatement of Torts, Section 548A,

comment b.
20

This point has been much emphasized by some commentators. See Edmund Kitch, The Theory and

Practice of Securities Disclosure, 61 Brook. L. Rev. 763, 772 (1995).
21

The word “bubble” – or its politer euphemism, “irrational exuberance” – does not appear in Professor

Fox’s article because it is not recognized by the lexicon of efficient market theory. Nonetheless, some
financial economists assign it considerable weight in explaining investor behavior. See Robert J. Shiller,
IRRATIONAL EXUBERANCE, 173-90 (2000).
22

Rule 10b-5 will be the plaintiff’s remedy of choice in this context, because damages under Section 11(e)

of the Securities Act of 1933 are cut off at “the price at which the security was offered to the public” (i.e.,
the original offering price in the IPO). See 15 U.S.C. §77k(e). Hence, there will be no damages under §11
unless and until the price in the secondary market drops below the initial offering price, which often does
not happen. To this degree, Section 11 is “bubble-proof,” but Rule 10b-5 is not.
23

Fox, supra note 5, at [29].

24

Id.

- 24 -

25

National Economic Research Associates (“NERA”) regularly tracks the trends and status of securities

class action litigation and publishes regular reports. Their most recent is Elaine Buckberg, Todd Foster, and
Stephanie Planich, “Recent Trends in Securities Class Action Litigation: 2003 Early Update” (NERA
February 2004). It finds that “there have been one-third fewer dismissals since SOX, a statistically
significant drop compared to the prior pace.” Id. at 4.
26

Id. at 5. This statistic is only for the first two years of the action’s life, but if a securities class action

survives that long, settlement becomes much more likely.
27

If only in a footnote, some skepticism needs to be expressed here about this idea of a loss that the market

never discovers. An ancient maxim of Wall Street is that “A bargain that stays a bargain is no bargain.” But
the other side of this coin should be that “A loss that never materializes is no loss.”
28

See Basic Inc. v. Levinson, 485 U.S. 224, 231-32 (1988) (quoting TSC Industries Inc. v. Northway, Inc.,

426 U.S. 438, 448-449 (1976)). In addition, the Court added that “there must be a substantial likelihood
that the disclosure … would have been viewed by the reasonable investor as having significantly altered the
‘total mix’ of information made available.” Id. at 232.
29

The corporation may well be partially insured for such liabilities. But, the cost of insurance is again

borne by all the shareholders.
30

While there are many studies of the plaintiff’s legal fees and expenses in securities litigation, I am aware

of none that add in the defendants’ costs in order to estimate the true net recovery, if any, for shareholders
as a class. Additional costs that might go into this equation include the cost of liability insurance, the
additional risk premium that auditors may charge because of liability risks, the diverted time of
management, and the imputed time of in-house counsel.
31

See Buckberg, Foster, and Planich, supra note 25, at 8. The highest recovery rate for investors was

apparently 7.2% in 1996. Id.
32

While Professor Fox and I agree that securities class actions need to be justified on this basis, most

deterrence comes from parallel claims against controlling shareholders and gatekeepers (such as auditors
and investment bankers). To be sure, corporate officers do not wish to be sued, and so even open market,
class actions based on stock drops generate some general deterrence. But from either a general tort law
perspective, it makes better sense to focus on who is the best cost avoider and impose liability on that

- 25 -

person. The obvious answer is that the senior management and/or the controlling persons of the issuer, or
the company’s gatekeepers, can do more to minimize the costs associated with materially misleading
disclosures than can dispersed shareholders.
Lest it be thought that I am viewing all litigation issues exclusively from the defendants’ perspective,
see John C. Coffee Jr., Gatekeeper Failure and Reform: The Challenge of Fashioning Relevant Reforms,
84 Boston Univ. L. Rev. 301 (2004) (proposing stricter liability standards for gatekeepers). Litigation
against gatekeepers and controlling persons, or against the corporation itself in the primary market context,
makes far more sense than litigation against a public corporation with dispersed ownership in the secondary
market context.
33

Fox, supra note 5, at [35-36]

34

501 U.S. 350 (1991).

35

Id. at 359.

36

15 U.S.C. § 78r(a). It is arguable, I concede, that the phrase “affected by such statement” could only

require that there be some price inflation and not that there be any subsequent price decline.
37

Section 18 does not seem to expressly contemplate liability for an omission (although statements made

could be misleading because of omissions).
38

485 U.S. 224 (1988).

39

Id. at 245.

40

I do not mean to endorse this argument, but only to point to the conclusion to which a “plain meaning”

approach may lead.
41

See 15 U.S.C. § 78i(e).

42

Id.

43

Because such a holder can still sell the stock at the inflated price, it is linguistically difficult to see how

this plaintiff has “sustained” any injury. Such a plaintiff is rather only exposed to potential future injury.
44

15 U.S.C. § 78u-4(b)(4).

45

Restatement (Second) of Torts (1977) § 548A, comment b.

- 26 -

46

It might be argued that Section 548A is addressing only the primary market context where the defendant

sells the stock to the plaintiff. But, a fortiori, the standard should be even stricter in the secondary market
context where the judgment falls on generally non-culpable shareholders.
47

Id.

48

Section 12(b) of the Securities Act of 1933, 15 U.S.C. § 77(l)(b).

49

Section 11(e) of the Securities Act of 1933 allows the defendant to establish an affirmative defense by

proving that claimed damages represent “other than the depreciation in value of such security resulting
from the misstatement or omission in the registration statement ….” See 15 U.S.C. § 77k(e). Section 12(b),
which was added in 1995, was modeled on Section 11(e) and also requires the defendant to disprove loss
causation. See 11 U.S.C. § 77(l)(b). Both provisions refer to “depreciation in value”, thus indicating that
there must be a post-purchase decline in price. In contrast, Section 21D(b)(4) places the burden of proof on
the plaintiff, reflecting in part the fact that it is suing a non-trading issuer.
50

This point is made in the Government’s amicus brief. See Brief for the United States at 25.

51

See 15 U.S.C. § 78u-4(e).

52

For Broudo’s facts, see supra note 11.

53

If defendants were to issue a press release summarizing plaintiff’s charges when plaintiff filed the class

action, this step might serve to trigger the express language of this section.
54

See text supra at notes 38 to 40. I do not expect that Broudo will be used as the vehicle for such a

reconsideration, but pregnant hints could be dropped.
55

See Brief for United States at 15.

56

Id. at 19. At this point, we are back to allowing the factfinder to make a speculative judgment

uncorroborated by any objective market evidence.
57

Id. (emphasis in original). This could happen, it adds, if the company simultaneously “corrected the false

information and at the same time issued unrelated positive information.” Id. at 20. In truth, there seem to be
some internal inconsistencies or at least tensions in the Solicitor General’s position. At page 15 of the Brief
for the United States, the Solicitor General argues that the original price inflation must be “eliminated or
reduced,” but at pages 19 to 20, the brief seemingly backs off this position and claims that simultaneous
price movements in opposite directions are sufficient to show loss causation. See Brief for the United States

- 27 -

at 15 and 19-21. This invites very speculative decision-making by the factfinder. One suspects that the SEC
resisted any stronger position on loss causation.
58

In thinner markets, rescissionary remedies may be appropriate, and that topic is not addressed in this

brief comment. I recognize that the issue of damages is distinct from the issue of loss causation, but both
Sections 11 and 12b limit damages to “depreciation in value,” and there is little reason to extend Rule 10b5 further in this context. Finally, in requiring a stock market decline, I do not mean to limit that decline to
only those in response to a corrective statement by the corporation. The market may learn in other ways:
Barron’s may publish an expose on the corporation’s accounting; short sellers may organize a bear raid on
its stock – all these ways should count.

- 28 -

